niclosamide has been researched along with Local Neoplasm Recurrence in 3 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral Squamous Cell Carcinoma (OSCC) is one of the major causes of cancer related deaths worldwide." | 1.51 | CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma. ( Pindiprolu, SH; Pindiprolu, SKSS, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bansard, L | 1 |
| Bouvet, O | 1 |
| Moutin, E | 1 |
| Le Gall, G | 1 |
| Giammona, A | 1 |
| Pothin, E | 1 |
| Bacou, M | 1 |
| Hassen-Khodja, C | 1 |
| Bordignon, B | 1 |
| Bourgaux, JF | 1 |
| Prudhomme, M | 1 |
| Hollande, F | 1 |
| Pannequin, J | 1 |
| Pascussi, JM | 1 |
| Planque, C | 1 |
| Rai, R | 1 |
| Dey, DK | 1 |
| Benbrook, DM | 1 |
| Chandra, V | 1 |
| Pindiprolu, SH | 1 |
| Pindiprolu, SKSS | 1 |
3 other studies available for niclosamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mice; | 2022 |
Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.
Topics: Animals; Apoptosis; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female | 2023 |
CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma.
Topics: AC133 Antigen; Apoptosis; Carcinoma, Squamous Cell; Drug Carriers; Drug Delivery Systems; Epithelial | 2019 |